Literature DB >> 35373386

Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces.

Adlin Pinheiro1,2, Serkalem Demissie1,2, Ashlea Scruton2, Andreas Charidimou3, Pedram Parva4,5, Charles DeCarli6, Sudha Seshadri2,7, José R Romero2,3.   

Abstract

OBJECTIVE: Enlarged perivascular spaces have emerged as markers of cerebral small vessel disease and are linked to perivascular drainage dysfunction. The apolipoprotein E-ɛ4 (APOE-ɛ4) allele is the strongest genetic risk factor for cerebral amyloid angiopathy and Alzheimer's neuropathology, but the underlying mechanisms remain unclear. We studied the relationship between APOE-ɛ4 and the topography and burden of enlarged perivascular spaces to elucidate underlying mechanisms between APOE-ɛ4 and adverse clinical outcomes.
METHODS: We included 3,564 Framingham Heart Study participants with available genotypes and magnetic resonance imaging. Enlarged perivascular spaces in the basal ganglia and centrum semiovale were rated using a validated scale. We related APOE-ɛ4 allele presence to high burden of enlarged perivascular spaces in each region and a mixed score reflecting high burden in both regions using multivariable logistic regression. Exploratory analyses incorporated presence of cerebral microbleeds and assessed effect modification by hypertension.
RESULTS: Mean age was 60.7 years (SD = 14.6), 1,644 (46.1%) were men, 1,486 (41.8%) were hypertensive, and 836 (23.5%) participants were APOE-ɛ4 carriers. APOE-ɛ4 was associated with high burden of enlarged perivascular spaces in the centrum semiovale (odds ratio [OR] = 1.45, 95% confidence interval [CI] = 1.16, 1.81) and mixed regions (OR = 1.37, 95% CI = 1.11, 1.68). Associations were slightly stronger in hypertensive subjects.
INTERPRETATION: The APOE-ɛ4 allele plays a modest role in the burden of enlarged perivascular spaces in the centrum semiovale. Further studies are needed to clarify the underlying small vessel disease type in community-dwelling individuals with predominant centrum semiovale enlarged perivascular spaces, which may be hypertensive angiopathy in our sample. ANN NEUROL 2022;92:23-31.
© 2022 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35373386      PMCID: PMC9233108          DOI: 10.1002/ana.26364

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  33 in total

1.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

2.  Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.

Authors:  Nicolas Raposo; Mélanie Planton; Pierre Payoux; Patrice Péran; Jean François Albucher; Lionel Calviere; Alain Viguier; Vanessa Rousseau; Anne Hitzel; François Chollet; Jean Marc Olivot; Fabrice Bonneville; Jérémie Pariente
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-29       Impact factor: 9.236

3.  Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

Authors:  José Rafael Romero; Sarah R Preis; Alexa Beiser; Charles DeCarli; Anand Viswanathan; Sergi Martinez-Ramirez; Carlos S Kase; Philip A Wolf; Sudha Seshadri
Journal:  Stroke       Date:  2014-04-08       Impact factor: 7.914

Review 4.  Perivascular spaces, glymphatic dysfunction, and small vessel disease.

Authors:  Humberto Mestre; Serhii Kostrikov; Rupal I Mehta; Maiken Nedergaard
Journal:  Clin Sci (Lond)       Date:  2017-08-10       Impact factor: 6.124

5.  Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.

Authors:  Connie W Tsao; Ramachandran S Vasan
Journal:  Int J Epidemiol       Date:  2015-12       Impact factor: 7.196

6.  Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Authors:  Alessandro Biffi; Akshata Sonni; Christopher D Anderson; Brett Kissela; Jeremiasz M Jagiella; Helena Schmidt; Jordi Jimenez-Conde; Björn M Hansen; Israel Fernandez-Cadenas; Lynelle Cortellini; Alison Ayres; Kristin Schwab; Karol Juchniewicz; Andrzej Urbanik; Natalia S Rost; Anand Viswanathan; Thomas Seifert-Held; Eva-Maria Stoegerer; Marta Tomás; Raquel Rabionet; Xavier Estivill; Devin L Brown; Scott L Silliman; Magdy Selim; Bradford B Worrall; James F Meschia; Joan Montaner; Arne Lindgren; Jaume Roquer; Reinhold Schmidt; Steven M Greenberg; Agnieszka Slowik; Joseph P Broderick; Daniel Woo; Jonathan Rosand
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

7.  Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study.

Authors:  Xiao Luo; Yerfan Jiaerken; Xinfeng Yu; Peiyu Huang; Tiantian Qiu; Yunlu Jia; Kaicheng Li; Xiaojun Xu; Zhujing Shen; Xiaojun Guan; Jiong Zhou; Minming Zhang; For The Alzheimer's Disease Neuroimaging Initiative Adni
Journal:  Oncotarget       Date:  2017-07-04

8.  Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.

Authors:  Sara Shams; Juha Martola; Andreas Charidimou; Mykol Larvie; Tobias Granberg; Mana Shams; Maria Kristoffersen-Wiberg; Lars-Olof Wahlund
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

9.  Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis.

Authors:  Sytze P Rensma; Thomas T van Sloten; Lenore J Launer; Coen D A Stehouwer
Journal:  Neurosci Biobehav Rev       Date:  2018-04-13       Impact factor: 8.989

View more
  1 in total

Review 1.  Biomarkers involved in the pathogenesis of cerebral small-vessel disease.

Authors:  Xiaolu Liu; Pei Sun; Jing Yang; Yuhua Fan
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.